|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 07840744.2 (espacenet) (Federated) (European Patent Register), 20070807 | | Patent/reg. no. and date | DK/EP 2068930, 20120919 | | Publication date | 20090617 | | Priority no. and date | US 836250 P, 20060807, US 856144 P, 20061101 | | EP pub. no. and date |
EP 2068930 20090617 | | Effective date | | | Applicant/owner | AbbVie Biotherapeutics Inc., 1500 Seaport Boulevard
Redwood City CA 94063, US | | Applicant ref. no. | P010536EPDK1 | | Inventor | AFAR, Daniel, 2882 Arlington Place
Fremont, California 94555, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) | | Title | Sammensætninger og fremgangsmåder under anvendelse af anti-CS1-antistoffer til at behandle multiple myelomer | | Int. application no. | US2007075401 | | Int. publication no. | WO2008019376 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
